Table 1 Clinicopathologic characteristics HCC patients

No. of patients

365

243

115

Age (%)

 < 45

42 (11.5%)

5 (2.1%)

7 (6.08%)

 ≥ 45

323 (88.5%)

238 (97.9%)

108 (93.92%)

Gender (%)

 Female

119 (32.6%)

61 (25.1%)

22 (19.13%)

 Male

246 (67.4%)

182 (74.9%)

93 (80.87%)

Grade (%)

 Grade 1

55 (15.1%)

30 (12.3%)

50 (43.5%)

 Grade 2

175 (47.9%)

152 (62.3%)

 Grade 3

118 (32.3%)

20 (8.2%)

62 (53.9%)

 Grade 4

12 (3.3%)

1 (0.4%)

 Unknown

5 (1.4%)

40 (16.8%)

3 (2.6%)

Tumor stage (%)

 I

170 (46.6%)

36 (14.8%)

55 (47.83%)

 II

84 (23.0%)

110 (45.3%)

35 (30.43%)

 III

83 (22.7%)

76 (31.3%)

21 (18.26%)

 IV

4 (1.09%)

21 (8.6%)

3 (2.61%)

 Unknown

24 (6.6%)

1 (0.87%)

T stage (%)

 T1

180 (49.3%)

NR

NR

 T2

91 (24.9%)

NR

NR

 T3

78 (21.4%)

NR

NR

 T4

13 (3.6%)

NR

NR

 Tx

1 (0.3%)

NR

NR

 Unknown

2 (0.5%)

NR

NR

N stage (%)

 N0

248 (67.9%)

NR

NR

 N1

4 (1.09%)

NR

NR

 Nx

112 (30.7%)

NR

NR

 Unknown

1 (0.3%)

NR

NR

M stage (%)

 M0

263 (72.1%)

NR

NR

 M1

3 (0.8%)

NR

NR

 Mx

99 (27.1%)

NR

NR

Survival status

 OS days (median)

556

780

423.4

 Censored (%)

126 (34.5%)

44 (18.1%)

23 (20%)